Changeflow GovPing Healthcare & Life Sciences Oxygen Modulator Hypoxic/Hyperoxic Tabata Train...
Routine Notice Added Final

Oxygen Modulator Hypoxic/Hyperoxic Tabata Training Study

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH registered a clinical trial (NCT07551869) examining how breathing air with different oxygen concentrations during high-intensity interval training (Tabata protocol) affects aerobic capacity, ventilatory thresholds, blood lactate levels, and perceived exertion. The three-week study will enroll participants randomly assigned to breathe hyperoxic or hypoxic air during training sessions. This is a research study registry entry with no compliance obligations.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

This document registers a clinical trial on ClinicalTrials.gov describing a physiological study on oxygen modulation during high-intensity interval training. The study will assess aerobic capacity and metabolic responses to hyperoxic and hypoxic breathing conditions using the Tabata protocol. There are no compliance obligations, enforcement actions, or regulatory changes associated with this study registration. Compliance officers can note this as informational research that does not create new regulatory requirements.

Archived snapshot

Apr 28, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Oxygen as a Metabolic Modulator: Divergent Physiological Adaptations to Hypoxic and Hyperoxic Tabata Training.

N/A NCT07551869 Kind: NA Apr 27, 2026

Abstract

The purpose of this study is to examine how breathing air with different oxygen concentrations (higher or lower than normal) during high-intensity interval training affects:

  • Aerobic capacity (VO₂max)
  • Ventilatory thresholds
  • Blood lactate levels
  • Perceived exertion This research aims to better understand how oxygen availability influences physiological adaptations to exercise.

If you agree to participate, you will undergo the following:

Baseline testing:

  • Cardiopulmonary exercise test (cycling until exhaustion)
  • Measurement of oxygen consumption, heart rate, and ventilatory thresholds
  • Blood lactate measurement (finger prick)

Training intervention (3 weeks):

  • 3 sessions per week (total of 9 sessions)
  • High-intensity interval training (Tabata protocol: 8 × 20 seconds effort / 10 seconds rest)
  • Exercise performed on an air-resistance cycle ergometer

During training, you will breathe either:

  • Hyperoxic air (high oxygen concentration) or
  • Hypoxic air (low oxygen concentration) You will be randomly assigned to one of these conditions.

Post-intervention testing:

• Same assessments as baseline

The risks associated with this study are similar to those encountered during high-intensity exercise:

  • Fatigue
  • Muscle soreness
  • Shortness of breath
  • Temporary discomfort from finger-prick blood sampling

Breathing altered oxygen concentrations (hypoxia or hyperoxia) may induce:

  • Mild dizziness
  • Increased breathing effort (hypoxia)
  • Sensations of ease or alt...

Conditions: Hyperoxia / High FiO₂ Exposure, Interval Training, HIIT, High Intensity Interval Training, VO2max, Hypoxia

Interventions: FIO2 modulation during HIIT protocol on assault bike

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 27th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Docket
NCT07551869

Who this affects

Applies to
Clinical investigators Healthcare providers Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Exercise physiology research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Clinical Operations Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!